1993 17 Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA

1993. 17. Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, Ling CC: Correlation

of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 2005, 63:672–682.PubMedCrossRef 18. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, Perez CA: Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999, 45:323–329.PubMed 19. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal Official Statement of the European Respiratory Society. Eur Rucaparib Respir J 1993,6(Suppl 16):5–40. 20. Prediletto R, Paoletti P, Fornai E, Perissinotto A, Petruzzelli S, STI571 supplier Formichi B, Ruschi

S, Palla A, Giannella-Neto A, Giuntini C: Natural course of treated pulmonary embolism Evaluation by perfusion lung scintigraphy, gas exchange, and chest roentgenogram. Chest 1990,97(3):554–61.PubMedCrossRef 21. COMMON TOXICITY CRITERIA (CTC) [http://​ctep.​cancer.​gov/​protocolDevelopm​ent/​electronic_​applications/​docs/​ctcv20_​4-30-992.​pdf] 22. LENT SOMA: Tables Radiother Oncol. 1995, 35:17–60.CrossRef 23. Common Terminology Criteria for Adverse Events (CTCAE): Version 4.02. [http://​evs.​nci.​nih.​gov/​ftp1/​CTCAE/​CTCAE_​4.​02_​2009-09-15_​QuickReference_​8.​5x11.​pdf] 24. Nishioka A, Ogawa Y, Hamada N, Terashima M, Inomata T, Yoshida S: Analysis of radiation pneumonitis and radiation-induced lung fibrosis in breast cancer patients after breast conservation treatment. Oncol Rep 1999, 6:513–517.PubMed 25. Wennberg B, Gagliardi G, Sundbom L, Svane G, Lind P: Early response of lung in breast cancer irradiation: radiologic density changes measured by ct and symptomatic radiation pneumonitis. Int J Radiat Oncol Biol Phys 2002, 52:1196–1206.PubMedCrossRef selleck 26. Fisher J, Scott C, Stevens R, Marconi B, Champion

L, Freedman GM, Asrari F, Pilepich MV, Gagnon JD, Wong G: Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97–13. Int J Radiat Oncol Biol Phys 2000,48(5):1307–10.PubMedCrossRef 27. Lind PA, Rosfors S, Wennberg B, Glas U, Bevegård S, Fornander T: Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning. Radiother Oncol 1998, 49:245–54.PubMedCrossRef 28. Dörr W, Bertmann S, Herrmann T: Radiation induced lung reactions in breast cancer therapy. Modulating factors and consequential effects. Strahlenther Onkol 2005,181(9):567–73.PubMedCrossRef 29.

Comments are closed.